| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/01/2008 | CN100422328C Glycorpotein antigen SIMA135 expressed in metastatic human tumor cells |
| 10/01/2008 | CN100422321C Disease-resistant plants and method of constructing the same |
| 10/01/2008 | CN100422320C DNA sequences encoding dystrophin minigenes and methods of use thereof |
| 10/01/2008 | CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 10/01/2008 | CN100422211C Antagonistic analogs in GH-RH inhibiting IGF-I and -II |
| 10/01/2008 | CN100422210C Recombinant protective protein from streptococcus pneumoniae |
| 10/01/2008 | CN100421730C Immunogenic composition |
| 10/01/2008 | CA2654894A1 Csf3r polypeptides and uses thereof |
| 09/30/2008 | US7430476 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 09/30/2008 | US7429693 Method for the production of plant seed with modified fiber content and modified seed coat |
| 09/30/2008 | US7429657 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules |
| 09/30/2008 | US7429656 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference |
| 09/30/2008 | US7429653 Stabilized soluble glycoprotein trimers |
| 09/30/2008 | US7429652 Expression vector comprising nucleotide sequences coding non-single-chain antigen-binding units for use in generating immunoglobulins for diagnosing and treating human disease |
| 09/30/2008 | US7429648 IREN protein, its preparation and use |
| 09/30/2008 | US7429647 Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use |
| 09/30/2008 | US7429643 POSH nucleic acids, polypeptides and related methods |
| 09/30/2008 | US7429641 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders |
| 09/30/2008 | US7429640 PRO6181 polypeptides |
| 09/30/2008 | US7429639 SSX-2 peptides presented by HLA class II molecules |
| 09/30/2008 | US7429563 Sequences of myeloperoxidase (MPO) that serve as albumin docking proteins (ADPs); e.g. sequence ELKSLNPRWDGE; conjugates with other drugs or biodrugs such as insulin to improve uptake via transcytosis |
| 09/30/2008 | US7429561 Method for stimulating cell growth using sponge protein hydrolysates |
| 09/30/2008 | US7429486 Recombinant production of mixtures of antibodies |
| 09/30/2008 | US7429472 wherein mutant hydrolase forms stable bond with rhodococcus dehalogenase substrate; beta-lactamases; fustion proteins; cell labelling; tissue target therapy |
| 09/30/2008 | US7429469 producing polyesters resulting from homopolymerization or copolymerization of a 3-hydroxyalkanoic acid(s) and having biodegradability and good physical properties using yeasts as hosts. By constructing at least one enzyme gene involved in polyester synthesis by adding a DNA coding a peroxisome-targeting |
| 09/30/2008 | US7429461 Genetic products differentially expressed in tumors and use thereof |
| 09/30/2008 | US7429454 DNA probes useful in detecting δ-endotoxin-encoding sequences and uses thereof |
| 09/30/2008 | US7429449 Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels |
| 09/30/2008 | US7429448 Therapeutic use of the SMR1 protein and active derivatives thereof |
| 09/30/2008 | US7429385 Isolated, genetic engineered polypeptide |
| 09/30/2008 | US7429384 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis |
| 09/30/2008 | US7429383 Improves the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function |
| 09/30/2008 | US7429380 Production of a multimeric protein by cell fusion method |
| 09/30/2008 | US7429379 TNF receptor action modulation |
| 09/30/2008 | CA2405716C Chemically modified novel erythropoietin stimulating protein compositions and methods |
| 09/30/2008 | CA2309766C Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 09/30/2008 | CA2305704C Peptide/lipid complex formation by co-lyophilization |
| 09/30/2008 | CA2285573C A method for stimulating red blood cell production |
| 09/30/2008 | CA2261989C Recombinant pox virus for immunization against tumor-associated antigens |
| 09/30/2008 | CA2261987C Vectors for inhibiting hiv and tumor growth |
| 09/30/2008 | CA2259140C Method of activating dendritic cells |
| 09/30/2008 | CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 09/30/2008 | CA1341581C Leukaemia inhibitory factor |
| 09/25/2008 | WO2008116171A1 Cyclic receptor-associated protein (rap) peptides |
| 09/25/2008 | WO2008115844A2 Stable, functional chimeric cytochrome p450 holoenzymes |
| 09/25/2008 | WO2008115596A2 Over expression of foldases and chaperones improves protein production |
| 09/25/2008 | WO2008115569A1 Method for inhibiting immune responses in mammals using muteins of fas ligand |
| 09/25/2008 | WO2008115440A1 Pharmacodynamically enhanced therapeutic proteins |
| 09/25/2008 | WO2008115303A2 Potent and selective mediators of cholesterol efflux |
| 09/25/2008 | WO2008115061A2 Dual targeting system |
| 09/25/2008 | WO2008114709A1 Biomarker specific to blood cell or specific to osteoclast differentiation |
| 09/25/2008 | WO2008114672A1 Cancer-specific biomarker |
| 09/25/2008 | WO2008114577A2 Antibacterial peptide |
| 09/25/2008 | WO2008114497A1 Gene associated with foam formation of acetic acid bacterium, acetic acid bacterium bred by modifying the gene and method for producing vinegar using the acetic acid bacterium |
| 09/25/2008 | WO2008114077A1 Constitutively active mutants of the prolactin receptor |
| 09/25/2008 | WO2008114020A2 Mutant g-protein coupled receptors and methods for selecting them |
| 09/25/2008 | WO2008113970A2 Peptides |
| 09/25/2008 | WO2008113606A1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/25/2008 | WO2008113601A1 Glp-1 fusion peptides conjugated to polymer(s), their production and use |
| 09/25/2008 | WO2008113597A1 Peptides for treating multiple myeloma |
| 09/25/2008 | WO2008113589A1 Methods for industrial scale production of therapeutic complement factor h preparations from human plasma |
| 09/25/2008 | WO2008113536A1 Neurotrophic peptides |
| 09/25/2008 | WO2008113185A1 Antagonists of ligands and uses thereof |
| 09/25/2008 | WO2008113183A1 Use of francisella tularensis for prevention and treatment of allergic airway disorders |
| 09/25/2008 | WO2008113174A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 09/25/2008 | WO2008113145A1 Proteins from the webs of nephilengys cruentata, avicularia juruensis and parawixia bistriata spiders |
| 09/25/2008 | WO2008087224A3 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 09/25/2008 | WO2008080505B1 Novel specific arabinose transporter from the yeast pichia stipitis, and uses thereof |
| 09/25/2008 | WO2008077397A3 Method and means for concentrating, removing, and detecting gram-positive bacteria |
| 09/25/2008 | WO2008067223A3 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 09/25/2008 | WO2008048348A3 Broad spectrum antiviral compositions |
| 09/25/2008 | WO2008033333A3 Il-1 family variants |
| 09/25/2008 | WO2008029138A3 Peptides and methods |
| 09/25/2008 | WO2008029031A9 Pharmacodiagnostic test targeting oncology |
| 09/25/2008 | WO2008026225A3 A vaccine for chikungunya virus infection |
| 09/25/2008 | WO2007087420A8 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 09/25/2008 | WO2007081534A3 Method of producing catalytically active bace2 enzymes |
| 09/25/2008 | WO2007058878A3 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1) |
| 09/25/2008 | US20080235826 useful in the production of dwarf plants; type 5 serine/threonine protein phosphatase activity; production of plants sensitive to light signal transduction |
| 09/25/2008 | US20080235825 Methods and means for modulating cellulose biosynthesis in fiber producing |
| 09/25/2008 | US20080235817 Artificial mammalian chromosome |
| 09/25/2008 | US20080235816 Multiple inducible gene regulation system |
| 09/25/2008 | US20080235815 Generating transgenic avians via transformation of urogenital systems for use in expression of heterologous genes; bioreactors |
| 09/25/2008 | US20080235814 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom |
| 09/25/2008 | US20080235813 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 09/25/2008 | US20080234471 Dna sequence; open-reading frame; genetic engineering |
| 09/25/2008 | US20080234470 Kcnb: a novel potassium channel protein |
| 09/25/2008 | US20080234469 Binding to monoclonal antibodies; antitumor agents |
| 09/25/2008 | US20080234468 Isdolated nucleic acids; coding polypeptide; therapy for central nervous system disorders |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234466 Delivery method for the tumor-specific apoptosis-inducing activity of apoptin |
| 09/25/2008 | US20080234465 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 09/25/2008 | US20080234264 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| 09/25/2008 | US20080234257 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
| 09/25/2008 | US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 09/25/2008 | US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor |
| 09/25/2008 | US20080234215 DNA composition and uses thereof |
| 09/25/2008 | US20080234201 BH3 peptides and method of use thereof |
| 09/25/2008 | US20080234198 Amino acid sequences having C-terminal extensions or modifications, used as activators of G-protein coupled receptor kinases (VPAC2), for treating non-insulin-dependent or insulin-dependent diabetes; antidiabetic agents |
| 09/25/2008 | US20080234193 Von Willebrand factor-and factor VIII-polymer conjugates having a releasable linkage |